Recent Quarter Total Invested
$5.24 B
Recent Quarter Institutional Ownership Percentage
98.75%
Total Invested of Last Quarter
$2.67 B
Ownership Percentage of Last Quarter
96.82%
MoonLake Immunotherapeutics Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 11/14/2024 | 21.75 M | $1.10 B | 0.00% | 34.58% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 8.49 M | $428.28 M | 0.00% | 13.50% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 2.98 M | $150.27 M | 16.35% | 4.74% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 2.77 M | $139.67 M | 0.00% | 4.40% |
| CITADEL ADVISORS LLC | 11/14/2024 | 2.32 M | $117.12 M | 2.53% | 3.69% |
| HOLOCENE ADVISORS, LP | 11/14/2024 | 1.59 M | $79.92 M | -2.53% | 2.52% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.50 M | $75.42 M | 19.50% | 2.38% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 11/12/2024 | 1.17 M | $58.86 M | 4.45% | 1.86% |
| MARSHALL WACE, LLP | 11/14/2024 | 1.15 M | $58.20 M | 5.08% | 1.84% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 998,140 | $50.33 M | -2.31% | 1.59% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2024 | 931,480 | $46.97 M | 100.00% | 1.48% |
| FRED ALGER MANAGEMENT, LLC | 11/14/2024 | 666,574 | $33.61 M | 1.14% | 1.06% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2024 | 646,662 | $32.60 M | 100.00% | 1.03% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 580,789 | $29.28 M | 11.32% | 0.92% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 505,000 | $25.46 M | -72.33% | 0.80% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 500,000 | $25.21 M | -26.27% | 0.80% |
| CAMBER CAPITAL MANAGEMENT LP | 11/14/2024 | 441,000 | $22.24 M | 24.23% | 0.70% |
| VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 409,203 | $20.63 M | 602.55% | 0.65% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 400,785 | $20.21 M | 100.00% | 0.64% |
| FINEPOINT CAPITAL LP | 11/13/2024 | 388,835 | $19.61 M | 0.00% | 0.62% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 360,200 | $18.16 M | -38.35% | 0.57% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 356,836 | $17.99 M | 3.18% | 0.57% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 349,063 | $17.60 M | 1.70% | 0.56% |
| SATURN V CAPITAL MANAGEMENT LLC | 11/14/2024 | 298,974 | $15.07 M | 100.00% | 0.48% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2024 | 282,313 | $14.23 M | 0.00% | 0.45% |
| CANDRIAM S.C.A. | 11/13/2024 | 239,000 | $12.05 M | 0.00% | 0.38% |
| WOODLINE PARTNERS LP | 11/14/2024 | 232,430 | $11.72 M | 2.52% | 0.37% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 10/21/2024 | 229,029 | $11.55 M | 0.10% | 0.36% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 220,000 | $11.09 M | 0.00% | 0.35% |
| VICTORY CAPITAL MANAGEMENT INC | 11/05/2024 | 217,839 | $10.98 M | 24.71% | 0.35% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 215,834 | $10.66 M | 3.15% | 0.34% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 192,058 | $9.68 M | -48.46% | 0.31% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 172,634 | $8.70 M | -39.14% | 0.27% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 159,260 | $8.03 M | 100.00% | 0.25% |
| MORGAN STANLEY | 11/14/2024 | 130,598 | $6.58 M | 89.20% | 0.21% |
| GHOST TREE CAPITAL, LLC | 11/14/2024 | 128,411 | $6.47 M | -57.20% | 0.20% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 122,099 | $6.16 M | 125.96% | 0.19% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 118,126 | $5.96 M | 3.41% | 0.19% |
| AXA S.A. | 11/14/2024 | 104,342 | $5.26 M | 0.03% | 0.17% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 102,813 | $5.18 M | 1.57% | 0.16% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 100,000 | $5.04 M | -20.00% | 0.16% |
| STATE STREET CORP | 11/14/2024 | 87,637 | $4.42 M | 96.24% | 0.14% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 86,775 | $4.38 M | -25.48% | 0.14% |
| HARBOR CAPITAL ADVISORS, INC. | 10/29/2024 | 77,468 | $3.91 M | 100.23% | 0.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/28/2024 | 75,469 | $3.81 M | 100.00% | 0.12% |
| CONGRESS ASSET MANAGEMENT CO /MA | 10/28/2024 | 66,641 | $3.36 M | 100.00% | 0.11% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 62,030 | $3.13 M | 84.84% | 0.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 58,410 | $2.95 M | -0.15% | 0.09% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 51,267 | $2.58 M | -76.37% | 0.08% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 11/12/2024 | 50,000 | $2.52 M | 0.00% | 0.08% |
MoonLake Immunotherapeuticsinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of MLTX shares?
During the previous two years, 126 institutional investors and hedge funds held shares of MoonLake Immunotherapeutics. The most heavily invested institutionals were:
BVF INC/IL: 21.75 M
Cormorant Asset Management, LP: 8.49 M
PRICE T ROWE ASSOCIATES INC /MD/: 2.98 M
Avoro Capital Advisors LLC: 2.77 M
CITADEL ADVISORS LLC: 2.32 M
Holocene Advisors, LP: 1.59 M
-
What percentage of MoonLake Immunotherapeutics stock is owned by institutional investors?
98.75% of MoonLake Immunotherapeutics stock is owned by institutional investors.
-
How much institutional buying is happening at MLTX ?
Institutional investors have bought a total of 57.30 M shares in the last 24 months. This purchase volume represents approximately $3.13 B in transactions.